Freiburg, Germany

Martina Maurer

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Oncotest Gmbh. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martina Maurer. Retrieved from https://idiyas.com/inventor/martina-maurer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martina Maurer - Innovator in Tumor Response Prediction

Introduction

Martina Maurer is a prominent inventor based in Freiburg, Germany. She has made significant contributions to the field of oncology through her innovative research and development. Her work focuses on understanding how tumors respond to pharmaceutical compounds, which is crucial for personalized medicine.

Latest Patents

Martina holds a patent titled "Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds." This invention relates to a method for providing a gene expression profile that predicts the specific response of an individual tumor to a pharmaceutical compound. The patent also includes a microarray containing nucleotide sequences corresponding to predictive genes and a diagnostic kit that utilizes this microarray. She has 1 patent to her name.

Career Highlights

Martina is currently employed at Oncotest GmbH, where she continues her research in tumor response prediction. Her work is instrumental in advancing the understanding of how genetic profiles can inform treatment decisions for cancer patients.

Collaborations

Some of her notable coworkers include Niko Bausch and Heinz-Herbert Fiebig, who collaborate with her on various projects related to cancer research and diagnostics.

Conclusion

Martina Maurer is a key figure in the field of oncology, with her innovative patent contributing to the future of personalized cancer treatment. Her dedication to research and collaboration with other experts highlights her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…